Hambrecht & Quist Capital Management »

Arcus Biosciences Incorporated shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $667k 33k 20.31
2023-03-31 $599k 33k 18.24

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Arcus Biosciences Incorporated

BlackRock
Vanguard Group
FMR
Woodline Partners
State Street Corporation
Point72 Asset Management
Siren
Boxer Capital
Dimensional Fund Advisors
Ameriprise Financial
Alliancebernstein
Geode Capital Management
Parkman Healthcare Partners
Bnp Paribas Investment Partners
Decheng Capital

View all funds holding Arcus Biosciences Incorporated